4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 02-2021 | 12-2020 | 11-2020 | 08-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,999 | 11,990 | 11,990 | 19 | 7 |
| Receivables | 12,098 | 4,799 | 4,799 | N/A | N/A |
| Inventories | 426 | N/A | N/A | N/A | N/A |
| TOTAL | $41,523 | $20,844 | $20,844 | $32 | $32 |
| Non-Current Assets | |||||
| PPE Net | 5,565 | 5,082 | 5,082 | N/A | N/A |
| Investments And Advances | 0 | 0 | 0 | 14,608 | 14,506 |
| Intangibles | 19,262 | 19,792 | 19,792 | 0 | 0 |
| Other Non-Current Assets | 252 | 3,381 | 3,381 | 0 | 0 |
| TOTAL | $25,078 | $28,255 | $28,255 | $14,608 | $14,506 |
| Total Assets | $66,601 | $49,099 | $49,099 | $14,640 | $14,538 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,732 | 4,540 | 4,540 | 418 | 337 |
| Accrued Expenses | N/A | 2,557 | 2,557 | N/A | N/A |
| TOTAL | $9,835 | $8,509 | $8,509 | $418 | $337 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,022 | 1,792 |
| Deferred Revenues | N/A | 1,318 | 1,318 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 203 | 203 | 7,200 | 7,409 |
| TOTAL | $1,325 | $1,619 | $1,619 | $9,221 | $9,201 |
| Total Liabilities | $11,160 | $10,128 | $10,128 | $9,640 | $9,538 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 16,433 | N/A | 2,627 |
| Common Shares | 630 | 479 | 479 | 5,826 | 5,629 |
| Retained earnings | -235,106 | -148,235 | N/A | N/A | N/A |
| Other shareholders' equity | 66,356 | -24,149 | -24,149 | 0 | 0 |
| TOTAL | $55,441 | $38,971 | $38,971 | $5,000 | $5,000 |
| Total Liabilities And Equity | $66,601 | $49,099 | $49,099 | $14,640 | $14,538 |